A bid by the owner of Wegovy maker Novo Nordisk A/S to buy a key manufacturer presents an opening for the US Federal Trade ...
(Bloomberg) -- Catalent Inc. shares rose after the troubled contract drug manufacturer gave investors some reassurance about a slashed fiscal full-year outlook and the third delay to its quarterly ...
Pall Corp. (PLL) stock is rising after the company said it will be acquired by Danaher (DHR) for $13.8 billion. Pall Corp. (PLL) stock is rising after the company said it will be acquired by ...
SOMERSET, N.J. — SOMERSET, N.J. — Catalent Inc. (CTLT) on Wednesday reported a loss of $101 million in its fiscal third quarter. The Somerset, New Jersey-based company said it had a loss of 56 ...
Danaher stock (NYSE: DHR), a conglomerate with products in life sciences, biotechnology, and diagnostics fields, recently posted its Q1 results that exceeded the street expectations. The company ...
The deal was announced in February and Novo Nordisk Foundation has since refiled its application to the U.S. FTC seeking regulatory approval for it. Catalent in a regulatory filing on Friday said ...
WASHINGTON (AP) — WASHINGTON (AP) — Danaher Corp. (DHR) on Tuesday reported first-quarter profit of $1.09 billion. The Washington-based company said it had net income of $1.45 per share.
No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing ...
Catalent, Inc. is a holding company, which engages in the provision of delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer ...